Li et al. found that the tumor suppressive 3KR mutant of p53 retains the ability to regulate genes (e.g., TIGAR, GLS2 and GLUT3) that limit glucose uptake, glycolysis and ROS generation, implying those activities may be vital to tumor suppression [261]. The gene discussed is GLS2; the disease is neoplasm.